Literature DB >> 19368828

Association of SORL1 gene variants with Alzheimer's disease.

Heike Kölsch1, Frank Jessen, Jens Wiltfang, Piotr Lewczuk, Martin Dichgans, Stefan J Teipel, Johannes Kornhuber, Lutz Frölich, Isabella Heuser, Oliver Peters, Birgitt Wiese, Hanna Kaduszkiewicz, Hendrik van den Bussche, Michael Hüll, Alexander Kurz, Eckhart Rüther, Fritz A Henn, Wolfgang Maier.   

Abstract

SORL1 gene variants were described as risk factor of Alzheimer's disease (AD) additionally SORL1 gene variants were associated with altered Abeta(42) CSF levels in AD patients. In the present study we investigated the association of SORL1 gene variants (rs2070045 (SNP19), SORL1-18ex26 (SNP21), rs3824968 (SNP23), rs1010159 (SNP25)) with AD risk by using Cox proportional hazard model and Kaplan-Meier survival analysis in 349 AD patients and 483 controls, recruited from a multicenter study of the German Competence Network Dementias. The SNP21G-allele and a SORL1 haplotype consisting of the SNP19 T-allele, SNP21 G-allele and SNP23 A-allele (T/G/A) were associated with increased hazard ratios and an earlier age at onset of AD (SNP21: p=0.002; T/G/A haplotype: p=0.007). This effect was most pronounced in carriers of an additional APOE4 allele (SNP21: p=0.003; T/G/A haplotype: p=0.005). In conclusion, we found SORL1 gene variants located in the 3' region of the gene to be associated with increased AD risk and an earlier age at onset of AD in our Central-European population. Thus, our data support a role of SORL1 polymorphisms in AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19368828     DOI: 10.1016/j.brainres.2009.01.044

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  31 in total

1.  SorLA in glia: shared subcellular distribution patterns with caveolin-1.

Authors:  Iris K Salgado; Melissa Serrano; José O García; Namyr A Martínez; Héctor M Maldonado; Carlos A Báez-Pagán; José A Lasalde-Dominicci; Walter I Silva
Journal:  Cell Mol Neurobiol       Date:  2011-11-30       Impact factor: 5.046

Review 2.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

Review 3.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  No association of psychosis in Alzheimer disease with neurodegenerative pathway genes.

Authors:  Mary Ann A DeMichele-Sweet; Lambertus Klei; Bernie Devlin; Robert E Ferrell; Elise A Weamer; James E Emanuel; Oscar L Lopez; Robert A Sweet
Journal:  Neurobiol Aging       Date:  2010-11-18       Impact factor: 4.673

Review 5.  The genetics and neuropathology of Alzheimer's disease.

Authors:  Gerard D Schellenberg; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2012-05-23       Impact factor: 17.088

Review 6.  The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review.

Authors:  Christiane Reitz
Journal:  Mol Genet Genomics       Date:  2014-10-21       Impact factor: 3.291

7.  Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study.

Authors:  Robert A Sweet; David A Bennett; Neill R Graff-Radford; Richard Mayeux
Journal:  Brain       Date:  2010-02-10       Impact factor: 13.501

Review 8.  Dyslipidemia and the risk of Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

9.  Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1.

Authors:  Ziran Wang; Hongyan Lei; Mei Zheng; Yuxin Li; Yansen Cui; Fang Hao
Journal:  Mol Neurobiol       Date:  2015-11-27       Impact factor: 5.590

10.  Sortilin receptor 1 predicts longitudinal cognitive change.

Authors:  Chandra A Reynolds; Catalina Zavala; Margaret Gatz; Loryana Vie; Boo Johansson; Bo Malmberg; Erik Ingelsson; Jonathan A Prince; Nancy L Pedersen
Journal:  Neurobiol Aging       Date:  2013-01-11       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.